06/30/2025
3:05 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2025
10:21 AM | Casey Patrick John (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
9:31 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
3:23 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
9:05 AM | Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
10:18 AM | Casey Patrick John (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
9:03 AM | FMR LLC (Filed by)
Legend Biotech (Subject)
| Form SCHEDULE 13G/A | |
06/05/2025
7:22 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2025
10:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2025
8:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025
6:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for LEGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. |
05/12/2025
7:31 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2025
10:06 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2025
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025
2:47 PM | Legend Biotech (Subject)
Yeung Jessie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2025
2:41 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2025
11:15 AM | Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
10:42 AM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
6:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025
8:44 AM | Legend Biotech (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
3:01 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025
2:14 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:48 AM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:59 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:01 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024
6:35 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
2:08 PM | Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
7:46 AM | Legend Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/12/2024
6:03 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024
8:10 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:35 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
2:30 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:43 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
9:46 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
7:01 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
6:01 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024
6:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Top Picks for Trump’s Pro-Crypto America (Ad) Mark August 12th on your calendar.
27 of crypto's most successful minds are about to reveal everything… Claim your pass to the Crypto Community Summit here (free for a limited time) |
07/17/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
